“Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients After FAC Chemotherapy: A Carvedilol Trial”. 2024. International Journal of Integrated Health Sciences 12 (1): 55-64. https://doi.org/10.15850/ijihs.v12.n1.3570.